142 related articles for article (PubMed ID: 28380433)
1. Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma.
Fu CL; Pan B; Pan JH; Gan MF
Oncotarget; 2017 May; 8(20):33037-33046. PubMed ID: 28380433
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
3. MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma.
Changjun L; Feizhou H; Dezhen P; Zhao L; Xianhai M
Biomed Pharmacother; 2018 Dec; 108():347-354. PubMed ID: 30227328
[TBL] [Abstract][Full Text] [Related]
4. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.
Dong X; Ding W; Ye J; Yan D; Xue F; Xu L; Yin J; Guo W
Cell Biochem Funct; 2016 Oct; 34(7):491-496. PubMed ID: 27650047
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas.
Mao J; Yu H; Wang C; Sun L; Jiang W; Zhang P; Xiao Q; Han D; Saiyin H; Zhu J; Chen T; Roberts LR; Huang H; Yu L
Carcinogenesis; 2012 Dec; 33(12):2568-77. PubMed ID: 22971577
[TBL] [Abstract][Full Text] [Related]
6. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
7. Low metallothionein 1M expression association with poor hepatocellular carcinoma prognosis after curative resection.
Ding J; Lu SC
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808371
[TBL] [Abstract][Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of eukaryotic translation initiation factor 3H is associated with proliferation, invasion and tumorigenicity in human hepatocellular carcinoma.
Zhu Q; Qiao GL; Zeng XC; Li Y; Yan JJ; Duan R; Du ZY
Oncotarget; 2016 Aug; 7(31):49888-49901. PubMed ID: 27340783
[TBL] [Abstract][Full Text] [Related]
11. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
12. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
14. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
16. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
17. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
18. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
19. The effect and mechanism of metallothionein MT1M on hepatocellular carcinoma cell.
Zhang S; Huang Z; Zhou S; Wang B; Ding Y; Chu JZ; Wang XL
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):695-701. PubMed ID: 29461597
[TBL] [Abstract][Full Text] [Related]
20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
